Technical Analysis for PSTV - Plus Therapeutics, Inc.

Grade Last Price % Change Price Change
F 1.72 -0.58% -0.01
PSTV closed down 0.58 percent on Monday, March 18, 2024, on 70 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion -0.58%
Oversold Stochastic Weakness -0.58%
Outside Day Range Expansion 4.88%
Wide Bands Range Expansion 4.88%
Gapped Up Strength 4.88%
Oversold Stochastic Weakness 4.88%
Stochastic Buy Signal Bullish -2.82%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 10 hours ago
Possible Inside Day about 10 hours ago
Down 3% about 11 hours ago
Down 2 % about 11 hours ago
Down 1% about 12 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Plus Therapeutics, Inc. Description

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and manufacture of treatments for cancer and other diseases. Its lead product candidate is DocePLUS, a protein-stabilized PEGylated liposomal formulation of docetaxel for the treatment of small cell lung cancer. The company is also involved in developing DoxoPLUS, a generic PEGylated liposomal encapsulated doxorubicin to treat breast and ovarian cancer, multiple myeloma, and Kaposi's sarcoma. It has a license agreement with NanoTx, Corp. to develop and commercialize NanoTx's glioblastoma treatment. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Clinical Medicine Pharmaceutical Disease Drugs Ovarian Cancer Small Cell Lung Cancer Blastoma Multiple Myeloma Glioblastoma Sarcoma Stage Pharmaceutical Pegylation Breast And Ovarian Cancer Doxorubicin Docetaxel

Is PSTV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.1
52 Week Low 0.9694
Average Volume 33,485
200-Day Moving Average 2.03
50-Day Moving Average 1.95
20-Day Moving Average 1.87
10-Day Moving Average 1.78
Average True Range 0.16
RSI (14) 43.18
ADX 13.43
+DI 17.10
-DI 25.09
Chandelier Exit (Long, 3 ATRs) 1.78
Chandelier Exit (Short, 3 ATRs) 2.07
Upper Bollinger Bands 2.18
Lower Bollinger Band 1.56
Percent B (%b) 0.26
BandWidth 33.18
MACD Line -0.07
MACD Signal Line -0.05
MACD Histogram -0.0215
Fundamentals Value
Market Cap 7.78 Million
Num Shares 4.52 Million
EPS -5.87
Price-to-Earnings (P/E) Ratio -0.29
Price-to-Sales 2.42
Price-to-Book 3.40
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.86
Resistance 3 (R3) 1.86 1.81 1.84
Resistance 2 (R2) 1.81 1.78 1.81 1.83
Resistance 1 (R1) 1.77 1.75 1.74 1.77 1.82
Pivot Point 1.72 1.72 1.71 1.72 1.72
Support 1 (S1) 1.67 1.68 1.65 1.67 1.62
Support 2 (S2) 1.63 1.66 1.63 1.61
Support 3 (S3) 1.58 1.63 1.60
Support 4 (S4) 1.58